News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
8,578 Results
Type
Article (421)
Company Profile (1)
Press Release (8156)
Section
Business (1228)
Deals (169)
Drug Delivery (2)
Drug Development (2530)
FDA (628)
Job Trends (406)
News (4649)
Policy (602)
Tag
Academia (21)
Adcomms (2)
Alliances (411)
Alzheimer's disease (5)
Antibody-drug conjugate (ADC) (12)
Approvals (650)
Artificial intelligence (1)
Autoimmune disease (1)
Best Places to Work (415)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (38)
Cancer (161)
Cardiovascular disease (14)
CAR-T (3)
Cell therapy (8)
Cervical cancer (1)
Clinical research (2346)
Collaboration (6)
Complete response letters (1)
COVID-19 (36)
C-suite (4)
Data (196)
Diabetes (2)
Diagnostics (23)
Drug discovery (4)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (595)
Events (1338)
Executive appointments (4)
FDA (705)
Funding (5)
Gene editing (1)
Gene therapy (8)
GLP-1 (2)
Government (83)
Guidances (8)
Healthcare (179)
IgA nephropathy (2)
Immunology and inflammation (1)
Indications (4)
Infectious disease (36)
Inflammatory bowel disease (1)
IPO (67)
Job creations (11)
Layoffs (2)
Legal (26)
Liver cancer (2)
Lung cancer (29)
Lymphoma (27)
Machine learning (1)
Manufacturing (4)
MASH (3)
Medical device (70)
Medtech (70)
Mergers & acquisitions (112)
Metabolic disorders (6)
Neurodegenerative disease (1)
Neuroscience (7)
NextGen: Class of 2025 (48)
Non-profit (40)
Ovarian cancer (5)
Pain (2)
Pancreatic cancer (2)
Parkinson's disease (1)
Patents (1)
Patient recruitment (5)
People (219)
Phase I (579)
Phase II (872)
Phase III (1033)
Pipeline (65)
Postmarket research (125)
Preclinical (144)
Prostate cancer (5)
Radiopharmaceuticals (2)
Rare diseases (16)
Real estate (20)
Regulatory (583)
Reports (1)
Research institute (20)
Sickle cell disease (7)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (28)
Stomach cancer (1)
Supply chain (3)
Vaccines (8)
Date
Today (2)
Last 7 days (15)
Last 30 days (77)
Last 365 days (523)
2025 (437)
2024 (526)
2023 (585)
2022 (746)
2021 (846)
2020 (746)
2019 (582)
2018 (468)
2017 (453)
2016 (377)
2015 (489)
2014 (320)
2013 (224)
2012 (283)
2011 (225)
2010 (232)
Location
Africa (3)
Arizona (1)
Asia (593)
Australia (41)
California (126)
Canada (13)
China (13)
Connecticut (14)
Delaware (30)
Europe (1094)
Florida (13)
Georgia (4)
Illinois (14)
Indiana (21)
Japan (21)
Kentucky (2)
Maine (1)
Maryland (22)
Massachusetts (113)
Michigan (5)
Minnesota (10)
Missouri (2)
New Hampshire (1)
New Jersey (111)
New York (24)
North Carolina (24)
Northern California (70)
Ohio (2)
Pennsylvania (18)
Puerto Rico (3)
South America (8)
Southern California (34)
Tennessee (2)
Texas (9)
United States (570)
Utah (1)
Washington State (14)
Wisconsin (1)
8,578 Results for "platelet biogenesis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PHASE 3 STUDY OF NOVEL ANTI-PLATELET DRUG FOR HEART ATTACK REPORTS POSITIVE TOPLINE RESULTS
September 24, 2025
·
2 min read
Press Releases
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
September 4, 2025
·
5 min read
Press Releases
CELECOR COMPLETES MULTINATIONAL PHASE 3 REGISTRATIONAL STUDY OF NOVEL ANTI-PLATELET AGENT FOR HEART ATTACK
May 27, 2025
·
3 min read
Press Releases
PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate
April 30, 2025
·
3 min read
Press Releases
PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
May 8, 2025
·
4 min read
Press Releases
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma
May 14, 2025
·
6 min read
FDA
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
Cerus Corporation (Nasdaq: CERS) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of 12-month shelf life for INTERCEPT Platelet Processing Sets, from the date of manufacture, effective immediately.
March 26, 2024
·
4 min read
Press Releases
Prolocor to Present New Clinical Evidence at ACC 25 Supporting Use of PLATELET FCɣRIIA (PFCG) As Key Tool In Individualizing Dual Antiplatelet Therapy (DAPT)
February 20, 2025
·
3 min read
Business
Core Biogenesis and Nucleus Biologics Announce Strategic Collaboration for Manufacturing and Distribution of Cost-Effective and Sustainable Recombinant Proteins
n a joint effort to provide lower cost and more defined reagents and media to the cell and gene therapy market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, has signed a manufacturing, distribution, and collaboration agreement with Core Biogenesis, an innovator in the field of recombinant human proteins expressed in plants.
January 10, 2024
·
4 min read
Business
Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)
Prolocor, Inc. today announced the acceptance of its abstract titled ASSOCIATION BETWEEN PROGNOSTIC IMPLICATIONS OF PLATELET FCɣRIIA (PFCG) AND TREATMENT STRATEGY FOR MYOCARDIAL INFARCTION at The American College of Cardiology (ACC) Scientific Sessions 2024 in Atlanta.
February 20, 2024
·
3 min read
1 of 858
Next
